parkinson-s-disease

Documents about parkinson-s-disease

• A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients#833795ClinicalTrials.gov
• Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.#841848ClinicalTrials.gov
• Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease#852512ClinicalTrials.gov
• A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients#855651ClinicalTrials.gov
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations#856676ClinicalTrials.gov
• Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease.#856760ClinicalTrials.gov
• Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal#861764ClinicalTrials.gov
• Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms#864246ClinicalTrials.gov
• Local Fields Potentientals of the Subthalamic Nucleus in Patients With Parkinson's Disease#807356ClinicalTrials.gov
• Studying Automatic Movements in Patients With Parkinson's Disease#834396ClinicalTrials.gov
• Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease#858695ClinicalTrials.gov
• Effects of Osteopathic Manipulative Treatment on Postural Control in Parkinson's Disease/Pisa Syndrome Patients#860659ClinicalTrials.gov
• Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease#866442ClinicalTrials.gov
• Impact of Frequency-specific Subthalamic Nucleus Subregion Stimulation on Inhibitory Control in Parkinson's Disease#870904ClinicalTrials.gov
• Genetic landscape of Parkinson’s disease in the Personalized Parkinson Project cohort#130543Unpaywall
• A High-density Microelectrode for Human Neuronal Recordings#840866ClinicalTrials.gov
• Freezing of Gait in Parkinson's Disease: A Heterogeneous Phenomenon Across Assessment Tools#273302Europe PMC
• Idebenone Treatment of Early Parkinson's Diseasesymptoms#844124ClinicalTrials.gov
• Kinesia 360 Parkinson's Monitoring Study#854142ClinicalTrials.gov
• Integrating Eye Tracking and Inertial Sensing for Enhanced Freezing of Gait Detection in Parkinson's Disease#5577Europe PMC
• Cortically Mediated Muscle Responses to Balance Perturbations Increase with Perturbation Magnitude in Older Adults with and without Parkinson's Disease#5585Europe PMC
• Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems#120101Europe PMC
• Increased beta-HFO phase-amplitude coupling in the subthalamic nucleus during movement in Parkinson's disease#234998Europe PMC
• Reproductive factors and clinical features of Parkinson's disease#288359IRIS
• High-Fidelity Synthetic Dataset for Parkinson's Disease Detection#347372Figshare
• Gender differences in non-motor symptoms in Parkinson’s disease: a multicenter longitudinal study#456861IRIS
• Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia#836492ClinicalTrials.gov
• Quantification of Hsp90 in the Human Brain#849529ClinicalTrials.gov
• An Online Physical Activity Coaching Intervention for People With PD in Qatar#844292ClinicalTrials.gov
• Machine learning combined with WGCNA reveals potential calcium uptake-associated biomarkers in Parkinson's disease.#181845PubMed
• Combining rTMS and Video Game-based Dexterity Training to Improve Dexterity in Parkinson's Disease#826708ClinicalTrials.gov
• Robotic Gait Rehabilitation in Parkinson's Disease#828735ClinicalTrials.gov
• Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease#839517ClinicalTrials.gov
• Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease#840163ClinicalTrials.gov
• JAME, a Wearable Device to Control Tremor#857770ClinicalTrials.gov
• Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD#864936ClinicalTrials.gov
• Myeloid-Driven Inflammation in Prodromal Parkinson's Disease#180151bioRxiv / medRxiv
• Correlation Between Idiopathic Parkinson's Disease and Diabetes Mellitus#407866ClinicalTrials.gov
• Deep Brain Stimulation and Digestive Symptomatology#803838ClinicalTrials.gov
• Stimulation settings in subthalamic nucleus deep brain stimulation for parkinson's disease - a retrospective single-center observational study#620212Europe PMC
• Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results#642369Europe PMC
• Frontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts#664951Europe PMC
• A General Anesthesia Regimen for DBS Surgery in Patients With PD#851673ClinicalTrials.gov
• Use of CereGate Therapy for Freezing of Gait in PD#877610ClinicalTrials.gov
• Saliva and Extracellular Vesicles for Neurodegenerative Diseases#874407ClinicalTrials.gov
• ANAVEX2-73 Study in Parkinson's Disease Dementia#850469ClinicalTrials.gov
• Rare Variant Burden Analysis of Dystonia Genes in Parkinson's Disease#154942bioRxiv / medRxiv
• Gut microbiota-derived extracellular vesicles in Parkinson's disease.#457418NCBI PubMed Central
• DBS-related infections in Parkinson's disease: Incidence, risk factors, management and outcome#635205HAL (France)
• Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease#831853ClinicalTrials.gov